Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Pletscher

Showing results (31-40 of 151) with videos related to

Pageof 16
Sort By:
British Journal of Pharmacology|April 1, 1979
Shape change of blood platelets--a model for cerebral 5-hydroxytryptamine receptors?M Graf, A Pletscher
Journal of Neural Transmission|January 1, 1983
The 5-hydroxytryptamine receptor of blood plateletsA Pletscher, H Affolter
Clinical Pharmacology and Therapeutics|March 1, 1971
Selective rise in brain dopamine by inhibition of extracerebral levodopa decarboxylationA Pletscher, G Bartholini
Naunyn-Schmiedeberg'S Archives of Pharmacology|February 1, 1981
Liberation of catecholamines and 5-hydroxytryptamine from human blood-plateletsM Peyer, A Pletscher
European Journal of Pharmacology|March 21, 1977
Increase of striatal dopamine turnover by drugs: interference with granular storage or receptor blackade?A Saner, A Pletscher
Pharmacology & Therapeutics. Part B: General & Systematic Pharmacology|January 1, 1975
Decarboxylase inhibitorsG Bartholini, A Pletscher
British Journal of Pharmacology|February 1, 1985
Rapid intracellular release of calcium in human platelets by stimulation of 5-HT2-receptorsP Erne, A Pletscher
Advances in Biochemical Psychopharmacology|January 1, 1972
Drugs affecting monoamines in the basal gangliaG Bartholini, A Pletscher
Experientia|January 1, 1971
Atropine-induced changes of cerebral dopamine turnoverG Bartholini, A Pletscher
The Journal of Pharmacy and Pharmacology|February 1, 1978
Enhancement of 5-hydroxytryptamine synthesis in brain by monamine-depleting drugsA Saner, A Pletscher
Pageof 16

Showing results (31-40 of 151) with videos related to

Sort By:
Pageof 16
British Journal of Pharmacology|April 1, 1979
Shape change of blood platelets--a model for cerebral 5-hydroxytryptamine receptors?M Graf, A Pletscher
Journal of Neural Transmission|January 1, 1983
The 5-hydroxytryptamine receptor of blood plateletsA Pletscher, H Affolter
Clinical Pharmacology and Therapeutics|March 1, 1971
Selective rise in brain dopamine by inhibition of extracerebral levodopa decarboxylationA Pletscher, G Bartholini
Naunyn-Schmiedeberg'S Archives of Pharmacology|February 1, 1981
Liberation of catecholamines and 5-hydroxytryptamine from human blood-plateletsM Peyer, A Pletscher
European Journal of Pharmacology|March 21, 1977
Increase of striatal dopamine turnover by drugs: interference with granular storage or receptor blackade?A Saner, A Pletscher
Pharmacology & Therapeutics. Part B: General & Systematic Pharmacology|January 1, 1975
Decarboxylase inhibitorsG Bartholini, A Pletscher
British Journal of Pharmacology|February 1, 1985
Rapid intracellular release of calcium in human platelets by stimulation of 5-HT2-receptorsP Erne, A Pletscher
Advances in Biochemical Psychopharmacology|January 1, 1972
Drugs affecting monoamines in the basal gangliaG Bartholini, A Pletscher
Experientia|January 1, 1971
Atropine-induced changes of cerebral dopamine turnoverG Bartholini, A Pletscher
The Journal of Pharmacy and Pharmacology|February 1, 1978
Enhancement of 5-hydroxytryptamine synthesis in brain by monamine-depleting drugsA Saner, A Pletscher
Pageof 16